Glimway-PM1
Glimepiride 1 mg + Pioglitazone HCl eq. to Pioglitazone 15 mg + Metformin HCl 500 mg (Extended Release Tablets) is a combination oral medication used to manage **type 2 diabetes mellitus**. It helps control blood sugar levels through multiple mechanisms, including improved insulin sensitivity, increased insulin secretion, and reduced glucose production.
Uses
- Manages blood sugar levels in type 2 diabetes
- Used when diet, exercise, or single therapy are not sufficient
- Supports long-term glycemic control and reduces complications of diabetes
Key Benefits
- Glimepiride 1 mg: Stimulates the pancreas to release more insulin
- Pioglitazone 15 mg: Improves insulin sensitivity in muscle and fat tissues
- Metformin HCl 500 mg (Extended Release): Reduces hepatic glucose production and enhances insulin action
- Combination therapy provides better blood sugar control than single therapy
- Helps prevent diabetes-related complications when used alongside lifestyle measures
How to Use
- Take one tablet daily or as prescribed by your doctor
- Swallow the tablet whole with water, preferably after meals
- Do not crush, chew, or break the extended-release tablet
- Follow your doctor’s instructions and complete the full course
Side Effects
- Common side effects: Nausea, vomiting, stomach upset, mild dizziness
- Occasional reactions: Headache, bloating, weight gain
- Serious side effects (rare): Low blood sugar (hypoglycemia), heart failure symptoms, allergic reactions
Safety & Precautions
- Consult your doctor if pregnant, breastfeeding, or taking other medications
- Do not exceed the recommended dose
- Monitor blood sugar levels regularly
- Inform your doctor if you have liver, kidney, or heart conditions
- Keep out of reach of children
